Fig. 3From: Phase separation in cancer at a glanceAn innovative PROTAC, ARV-825, which links BRD4 to E3 ubiquitin ligase, effectively degrades BRD4 protein. ARV-825-induced BRD4 aggregation disrupts LLPS and suppresses BRD-4-dependent transcription. PROTAC proteolysis targeting chimeraBack to article page